AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...

Oct 27 (Reuters) - BioMarin Pharmaceutical (BMRN.O), opens new tab said on Monday it plans to divest its gene therapy, a product once expected to be a blockbuster treatment for a type of rare bleeding ...

Landmark Bio, LLC today announced the initiation of a new collaboration with Mass General Brigham to provide development and manufacturing services for cell and gene therapies originating from the ...

BOSTON and SEOUL, South Korea, Aug. 26, 2025 /PRNewswire/ -- iNtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering ...

After telegraphing an investigation in November, the FDA has moved to restrict the use of bluebird bio’s gene therapy Skysona in certain patients. The FDA has updated Skysona’s indication, allowing it ...

A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies. His work was reviled as reckless and unethical because, ...

EVANSTON, Ill.--(BUSINESS WIRE)--Flashpoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision-engineered structural nanomedicines, today announced the ...

Somewhere near the end of Barry Mazor’s fascinating “Blood Harmony: The Everly Brothers Story,” the long-retired and increasingly frail Phil Everly finds himself at a concert by Rosanne Cash at the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis startup is ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Wilson, CEO of Gemma Bio, called ...

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to ...